Empfehlung
13,4
Stark Verkaufen
Composite Score (0–100)
Insider (25%)
53.7
1 Insider, 25,4M $ Volumen
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Stammdaten
Unternehmen
| Name | Aurinia Pharmaceuticals Inc. |
|---|---|
| Ticker | AUPH |
| CIK | 0001600620 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Aurinia Pharmaceuticals Inc. |
Status
| Zuletzt geprüft | 2026-03-20 22:35:46.654041 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | TANG KEVIN | Director | Open Market Purchase | 184,208 | 14.22 | 2,619,437.76 | +107,0% | |
| 2026-03-03 | TANG KEVIN | Director | Open Market Purchase | 184,208 | 14.22 | 2,619,437.76 | +107,0% | |
| 2026-03-02 | TANG KEVIN | Director | Open Market Purchase | 115,792 | 14.21 | 1,645,404.32 | +67,2% | |
| 2026-03-02 | TANG KEVIN | Director | Open Market Purchase | 115,792 | 14.21 | 1,645,404.32 | +67,2% | |
| 2026-03-02 | TANG KEVIN | Director | Open Market Purchase | 83,561 | 14.33 | 1,197,429.13 | +48,9% | |
| 2026-03-02 | TANG KEVIN | Director | Open Market Purchase | 83,561 | 14.33 | 1,197,429.13 | +48,9% | |
| 2026-02-27 | TANG KEVIN | Director | Open Market Purchase | 1,600 | 14.38 | 23,008.00 | +0,9% | |
| 2026-02-27 | TANG KEVIN | Director | Open Market Purchase | 214,839 | 14.12 | 3,033,526.68 | +123,9% | |
| 2026-02-27 | TANG KEVIN | Director | Open Market Purchase | 300,000 | 13.90 | 4,170,000.00 | +170,3% | |
| 2026-02-27 | TANG KEVIN | Director | Open Market Purchase | 1,600 | 14.38 | 23,008.00 | +0,9% | |
| 2026-02-27 | TANG KEVIN | Director | Open Market Purchase | 300,000 | 13.90 | 4,170,000.00 | +170,3% | |
| 2026-02-27 | TANG KEVIN | Director | Open Market Purchase | 214,839 | 14.12 | 3,033,526.68 | +123,9% | |
| 2025-08-05 | TANG KEVIN | Director | Open Market Purchase | 200,000 | 11.68 | 2,336,000.00 | +95,4% | |
| 2025-08-04 | TANG KEVIN | Director | Open Market Purchase | 100,000 | 11.34 | 1,134,000.00 | +46,3% | |
| 2025-08-01 | TANG KEVIN | Director | Open Market Purchase | 1,000,000 | 10.12 | 10,120,000.00 | +413,3% | |
| 2025-08-01 | Keenan Greg | Officer, Chief Medical Officer | Open Market Sale | -20,000 | 10.50 | -210,000.00 | -8,6% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.